viimane versioon :
19/11/2024
uurimisrühmad - Department of Pharmaceutical and Pharmacological Sciences, University of Padua   pdf  
Itaalia
ülikool
Department of Pharmaceutical and Pharmacological Sciences, University of Padua
Padoue
Email
Viited   Viited   (1)  
1
Prolonging the stability of cetuximab (Erbitux®) and panitumumab (Vectibix®): An orthogonal assessment of physicochemical, biological and microbiological properties of original opened glass vials and diluted saline preparations.
Carpanese D, Rossi V, Di Paolo V, Quintieri L, Penna Zuccolotto G, Sebellin J, Saran C, Pipitone F, Miolo G, de Diana E et al. (valentina.rossi@iov.veneto.it)
Int J Pharm - 2024 - ; 649: 123643.

ingredientide nimekiri   molekulid uuritud   (2)  
vähiravimite Süsteravim Cetuximab
vähiravimite Süsteravim Panitumumab

  Mentions Légales